Literature DB >> 28325081

Lipid Deposition in Kidney Diseases: Interplay Among Redox, Lipid Mediators, and Renal Impairment.

Hua Su1, Cheng Wan1, Chun-Tao Lei1, Chun-Yun Zhang1, Chen Ye1, Hui Tang1, Yue Qiu1, Chun Zhang1.   

Abstract

Significance: The relationship between lipid disturbances and renal diseases has been studied for several decades, and it is well recognized that when the balance of renal lipid uptake, synthesis, oxidation, and outflow is disrupted, lipids will undergo oxidation, be sequestrated as lipid droplets, generate toxic metabolites, and cause nephrotoxicity in diverse renal diseases. Recent Advances: During renal disorders, redox signaling is a pivotal event promoting or resulting from lipid disorders. Accordingly, a vicious cycle of lipid redox dysregulation could be developed, accelerating the renal damage. Critical Issues: The aim of this concise review is to introduce the connection among redox, lipid abnormalities and kidney damage in various conditions. And we summarized current understanding of the lipid redox loop implicated in acute kidney injury, chronic kidney disease, metabolic abnormalities, aging, and genetic pitfalls. Future Directions: Despite recent advances, further investigations are required to clarify the complicated molecular and regulatory mechanisms among redox, lipid mediators and renal disorders. Moreover, exploring an ideal target for potential therapies should be discussed and studied in future. Antioxid. Redox Signal. 28, 1027-1043.

Entities:  

Keywords:  acute kidney injury; chronic kidney disease; lipid nephrotoxicity; metabolic renal disease; redox signaling

Year:  2017        PMID: 28325081     DOI: 10.1089/ars.2017.7066

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  7 in total

1.  LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring.

Authors:  Portia Ritter; Keyvan Yousefi; Juliana Ramirez; Derek M Dykxhoorn; Armando J Mendez; Lina A Shehadeh
Journal:  J Vis Exp       Date:  2018-11-17       Impact factor: 1.355

2.  Bioactive Lipids and Redox Signaling: Molecular Mechanism and Disease Pathogenesis.

Authors:  Pin-Lan Li; Erich Gulbins
Journal:  Antioxid Redox Signal       Date:  2018-01-24       Impact factor: 8.401

3.  APOL1 Risk Variants Associated with Serum Albumin in a Population-Based Cohort Study.

Authors:  Ninad S Chaudhary; Hemant K Tiwari; Bertha A Hidalgo; Nita A Limdi; Richard J Reynolds; Mary Cushman; Neil A Zakai; Leslie Lange; Suzanne E Judd; Cheryl A Winkler; Jeffrey B Kopp; Orlando M Gutiérrez; Marguerite R Irvin
Journal:  Am J Nephrol       Date:  2022-01-31       Impact factor: 4.605

4.  Repeated administration of the NSAID meloxicam alters the plasma and urine lipidome.

Authors:  Sol M Rivera-Velez; Liam E Broughton-Neiswanger; Martin Suarez; Pablo Piñeyro; Jinna Navas; Sandy Chen; Julianne Hwang; Nicolas F Villarino
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

Review 5.  Recent Progress on Lipid Intake and Chronic Kidney Disease.

Authors:  Ke Pei; Ting Gui; Chao Li; Qian Zhang; Huichao Feng; Yunlun Li; Jibiao Wu; Zhibo Gai
Journal:  Biomed Res Int       Date:  2020-04-24       Impact factor: 3.411

6.  Triglycerides to high-density lipoprotein cholesterol ratio is superior to triglycerides and other lipid ratios as an indicator of increased urinary albumin-to-creatinine ratio in the general population of China: a cross-sectional study.

Authors:  Jing Xue; Yuxia Wang; Bing Li; Songyan Yu; Anping Wang; Weiqing Wang; Zhengnan Gao; Xulei Tang; Li Yan; Qin Wan; Guijun Qin; Lulu Chen; Guang Ning; Yiming Mu
Journal:  Lipids Health Dis       Date:  2021-02-15       Impact factor: 3.876

Review 7.  Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities.

Authors:  Pei-Hui Lin; Pu Duann
Journal:  Front Physiol       Date:  2020-09-03       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.